We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Reduction of Pulmonary Artery Pressure in Patients Subjected to Cardiac Surgery

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01597427
First Posted: May 14, 2012
Last Update Posted: May 14, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Luiz Fernando dos Reis Falcao, Federal University of São Paulo
  Purpose
The aim of this study is to assess the ability of clonidine to reduce the mean pulmonary artery pressure in patients with pulmonary hypertension subjected to cardiac surgery.

Condition Intervention Phase
Anesthesia Drug: Clonidine Drug: Placebo Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: Intravenous Clonidine Does Not Reduce Pulmonary Artery Pressure in Patients Subjected to Cardiac

Resource links provided by NLM:


Further study details as provided by Luiz Fernando dos Reis Falcao, Federal University of São Paulo:

Primary Outcome Measures:
  • Reduction pulmonary artery pressure [ Time Frame: During intraoperative (hours) ]
    Assessed four times: before (T0) administration of 2 μg·kg-1 of intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately after ECC (T2), and 10 minutes after the injection of protamine (T3).


Secondary Outcome Measures:
  • Doses of Dobutamine [ Time Frame: During intraoperative (hours) ]
    Evaluate the need for using and dose of dobutamine immediately after extracorporeal circulation between groups.

  • Doses of Sodium nitroprusside [ Time Frame: During intraoperative (hours) ]
    Evaluate the need for using and dose of sodium nitroprusside immediately after extracorporeal circulation between groups.


Enrollment: 29
Study Start Date: March 2009
Study Completion Date: March 2012
Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Sham Comparator: Clonidine
Administration of 2 μg/kg of intravenous clonidine.
Drug: Clonidine
Administration of 2 μg/kg of intravenous clonidine
Placebo Comparator: Placebo
Injection of placebo solution.
Drug: Placebo
Injection of placebo solution.

Detailed Description:
Prospective, clinical-interventionist, randomized, and double-blind study. Patients with group 2 pulmonary hypertension will be included and subjected to cardiac surgery with extracorporeal circulation. Mean pulmonary artery pressure and the doses of dobutamine and sodium nitroprusside will be assessed four times: before (T0) administration of 2 μg/kg of intravenous clonidine or a placebo, 30 minutes after the onset of treatment (T1), immediately after extracorporeal circulation (T2), and 10 minutes after the injection of protamine (T3).
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Signing an informed consent form,
  • Aged 18 to 80 years
  • Pulmonary hypertension due to left heart disease,
  • Physical status 2 or 3 according to the classification system of the American Society of Anesthesiologists,
  • Subjected to cardiac circulation with extracorporeal circulation
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01597427


Locations
Brazil
Luiz Fernando dos Reis Falcao
Sao Paulo, SP, Brazil, 04024-002
Sponsors and Collaborators
Federal University of São Paulo
Investigators
Study Chair: Luiz Fernando R Falcao, Ph.D. Federal University of Sao Paulo
Principal Investigator: Benedito B Joao, MD Federal University of São Paulo
  More Information

Responsible Party: Luiz Fernando dos Reis Falcao, Clinical Professor, Federal University of São Paulo
ClinicalTrials.gov Identifier: NCT01597427     History of Changes
Other Study ID Numbers: UNIFESP-02
First Submitted: May 8, 2012
First Posted: May 14, 2012
Last Update Posted: May 14, 2012
Last Verified: May 2012

Keywords provided by Luiz Fernando dos Reis Falcao, Federal University of São Paulo:
Clonidine
Hypertension Pulmonary
Cardiac Surgical Procedures

Additional relevant MeSH terms:
Clonidine
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Antihypertensive Agents
Sympatholytics
Autonomic Agents
Adrenergic alpha-2 Receptor Agonists
Adrenergic alpha-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action